Oxford Global is proud to present the Microbiome Discovery and Development Congress taking place on the 12th & 13th June 2017 in Berlin, Germany. This exciting conference showcases world-class speakers discussing novel strategies in microbiome research, challenges of commercialising the microbiome and latest therapeutic trends.

In recent years, there has been a substantial growth in interest in the microbiome. As of yet, no drugs have been approved, however with numerous therapeutics in clinical development the microbiome is set to revolutionise disease therapeutics, diagnostics and preventative medicine. The emerging microbiome market is expected to reach US$658 million by 2023.